Minitran (Glyceryl Trinitrate)

Glyceryl trinitrate, the active ingredient in Minitran, is an organic nitrate presented as a transdermal patch for transdermal use. It treats and prevents angina pectoris in patients with chronic stable angina.

GNH USA supplies Minitran as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Minitran, an organic nitrate used in the management of coronary artery disease, is indicated for: - Prophylaxis of angina pectoris: reduces the frequency of angina attacks during daily activities. - Management of chronic stable angina: improves exercise tolerance and reduces chest pain episodes. - Prevention of exertional angina: provides continuous nitrate delivery to avert attacks triggered by physical stress.

Minitran may cause a range of adverse reactions.

Common Side Effects: - Headache: throbbing pain often occurring shortly after patch application. - Dizziness: light‑headed sensation due to blood pressure changes. - Flushing: warmth and redness of the skin. - Hypotension: mild drop in blood pressure, especially when standing. - Skin irritation at the patch site: redness or itching where the patch adheres. - Nausea: unsettled stomach feeling.

Serious or Rare Side Effects: - Severe hypotension: marked blood pressure reduction leading to fainting. - Syncope: sudden loss of consciousness. - Tachycardia: rapid heart rate as a reflex response. - Allergic reaction: rash, swelling, or severe skin necrosis. - Methemoglobinemia: rare blood disorder causing reduced oxygen delivery. - Anaphylaxis: life‑threatening systemic allergic response.

Before initiating therapy, clinicians should consider several safety measures. - Assess cardiovascular status: evaluate blood pressure and heart rate prior to starting treatment. - Avoid concurrent use with phosphodiesterase‑5 inhibitors: increased risk of profound hypotension. - Monitor for tolerance development: efficacy may diminish over time, requiring dose adjustments. - Educate patient on patch removal schedule: replace patches as prescribed to prevent overdose. - Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Minitran can interact with several medication classes.

Major Interactions (Avoid): - Sildenafil, tadalafil, and other PDE‑5 inhibitors: may cause severe hypotension. - Other nitrates (e.g., isosorbide dinitrate): additive vasodilatory effect leading to dangerous blood pressure drops.

Moderate Interactions (Monitor Closely): - Antihypertensives such as ACE inhibitors or beta‑blockers: may enhance blood pressure‑lowering effects. - Alcohol: can increase vasodilatory response and dizziness. - Diuretics: may potentiate hypotensive episodes.